StockWatch
·
Pharmaceuticals
Management Change10 Aug 2026, 04:24 pm

Mankind Pharma Appoints Anish Vanraj Bafna as Independent Director

AI Summary

Mankind Pharma Ltd has announced the appointment of Mr. Anish Vanraj Bafna as an Additional Director, designated as a Non-Executive Independent Director. The appointment was approved by the Board of Directors at a meeting held on August 10, 2026, based on the recommendation of the Nomination and Remuneration Committee. Mr. Bafna's appointment is for a term of 5 consecutive years, subject to member approval via postal ballot. He brings over 30 years of experience in the healthcare and medical devices sector, including significant leadership roles at Healthium Medtech Limited and Baxter International. Mr. Bafna is not related to any existing directors or promoters and meets the independence criteria.

Key Highlights

  • Anish Vanraj Bafna appointed Non-Executive Independent Director.
  • Appointment is for a 5-year term, pending member approval.
  • Bafna has 30+ years of experience in healthcare and medical devices.
  • He is not related to any promoters or existing directors.
  • Bafna meets independence criteria as per regulations.